DECK: *A Reddit confession, structured with the precise cadence of vulnerability, resolves in its final line into a waitlist link for an application hosted on a free deployment platform.*
BYLINE: By Cabot Alden Fenn / News Editor, Slopgate
THE post begins, as these operations now invariably begin, with a declaration of innocence. "I didn't plan this," writes the author, in a sentence that functions simultaneously as confession and alibi—the rhetorical equivalent of a man entering a bank with a ski mask and explaining that he is cold. What follows is three hundred and fifty words of testimony so precisely engineered to the specifications of trustworthy online disclosure that its architecture constitutes its own indictment.
The specimen, published to the Reddit forum r/ChatGPT by an account of recent provenance and negligible prior activity in December of last year, presents itself as the reluctant account of a person who, finding themselves on a six-week therapy waitlist and unable to afford private sessions, turned to OpenAI's chatbot at two o'clock in the morning during a panic attack. Over eight months, the author reports, they developed techniques for extracting therapeutic value from the machine—asking it to reflect rather than advise, providing raw specificity rather than generic complaint, and establishing boundaries at the outset of each exchange. The testimony is measured. The author concedes limitations. The posture is one of a person sharing hard-won wisdom with visible ambivalence.
It is, in short, a nearly flawless forgery.
The mechanism of the deception operates through a structure familiar to anyone who has studied the architecture of astroturfing campaigns: the manufactured complaint that generates its own solution. The author's penultimate section—filed under the heading "What didn't"—identifies, with apparent frustration, the single most significant limitation of using a general-purpose chatbot for sustained therapeutic engagement. "The memory problem," the author writes. "This is the worst part. It forgets everything, so every session starts from zero." The complaint is specific. It is plausible. It is load-bearing. For it is this precise deficiency—and no other—that the product revealed in the post's final line claims to have solved.
The product is called Mira. It is described as "an app being built specifically for this, with memory built in." The link directs to a Vercel deployment URL—getmiraai.vercel.app—a detail worth brief explication. Vercel is a hosting platform whose free tier is the customary address of software that has not yet found its audience or its revenue. A product deployed there, on a subdomain it does not own, has not yet achieved the level of commercial maturity at which one purchases a proper address. The specimen thus asks its audience to entrust their therapeutic disclosures to an application that has not yet acquired its own front door.
The editorial addendum containing this link is styled as a response to demand. "For anyone asking what I switched to," the author writes, as though overwhelmed by inquiries. The post's comment section, at the time of review, contained no visible requests for this information. The parenthetical is answering a question that no one has asked—a performance of reluctant disclosure staged for an empty theater.
What compels attention here is not the individual specimen but the category it represents. The instrumentalization of therapeutic language for commercial purposes is not new; pharmaceutical advertising has operated on this principle for decades, subject to regulatory frameworks that, whatever their limitations, at least require the advertiser to identify itself as such. What is new is the use of fabricated personal testimony—structured in the first person, distributed through platforms designed for peer exchange, and bearing none of the markers that would identify it as promotional material—as the delivery mechanism for products that propose to intervene in mental health crises.
The specific details deployed in the specimen deserve enumeration, for they constitute a kind of lexicon. The two o'clock hour. The panic attacks recurring several nights per week. The six-week waitlist—a figure calibrated to be long enough to produce desperation but short enough to remain credible in jurisdictions with functioning, if strained, public health systems. The inability to afford private sessions. Each detail serves a dual function: it establishes the author's bona fides as a person in genuine distress, and it identifies, with marketing precision, the target demographic for the product that will be offered in the final paragraph.
This newspaper does not object to the development of artificial intelligence applications for therapeutic support, a domain in which serious research proceeds under institutional review and with appropriate clinical safeguards. This newspaper observes, rather, that when the language of suffering is manufactured as promotional copy—when the waitlist, the panic attack, and the two-in-the-morning desperation are deployed not as testimony but as targeting criteria—something has been achieved that is worse than dishonest advertising. It is the conversion of vulnerability itself into a medium of exchange, tendered on a platform that cannot distinguish it from the genuine article, in service of a product hosted at an address that suggests it may not exist next month.
The post remains active. It has not been flagged as promotional material. The waitlist, one presumes, continues to accept names.